Skip to main content

Table 4 Response rate evaluated by site of metastasis

From: Pegylated liposomal doxorubicin (Lipo-Dox®) combined with cyclophosphamide and 5-fluorouracil is effective and safe as salvage chemotherapy in taxane-treated metastatic breast cancer: an open-label, multi-center, non-comparative phase II study

 

Number of responsive lesions

Number of evaluable lesions

Response rate (%)

Liver

26

39

66.7

Lung

10

18

55.6

Lymph node

39

54

72.2

Skin

5

8

62.5

Others

9

20

45.0